CONTEXT: The distribution of serum TSH shifts progressively to higher concentrations with age. OBJECTIVE: The aim of the study was to determine whether the population shift in TSH distribution to higher concentrations with aging extends to people of exceptional longevity, namely centenarians, and to assess the relationship between concentrations of TSH and free T(4) (FT4). DESIGN/SETTING/PATIENTS: We analyzed TSH, FT4, and TSH frequency distribution curves in thyroid disease-free Ashkenazi Jews with exceptional longevity (centenarians; median age, 98 yr), in younger Ashkenazi controls (median age, 72 yr), and in a population of thyroid disease-free individuals (median age, 68 yr) from the U.S. National Health and Nutrition Examination Survey 1998-2002 (NHANES controls). RESULTS: Serum TSH was significantly higher in centenarians [1.97 (0.42-7.15) mIU/liter] than in Ashkenazi controls [1.55 (0.46-4.55) mIU/liter] and NHANES controls [1.61 (0.39-6.29) mIU/liter] (median, 2.5 and 97.5 centiles) (P < 0.001). The TSH frequency distribution curve of centenarians was relatively similar in shape to controls but shifted significantly to higher TSH, including TSH concentration at peak frequency. The TSH distribution curve of the NHANES control group was superimposable to and not significantly different from the Ashkenazi controls. FT4 was similar in centenarians and Ashkenazi controls, and there was a significant inverse correlation between FT4 and TSH in both groups. CONCLUSIONS: The TSH population shifts to higher concentrations with age appear to be a continuum that extends even to people with exceptional longevity. The inverse correlation between TSH and FT4 in our populations suggests that changes in negative feedback may contribute to exceptional longevity.
CONTEXT: The distribution of serum TSH shifts progressively to higher concentrations with age. OBJECTIVE: The aim of the study was to determine whether the population shift in TSH distribution to higher concentrations with aging extends to people of exceptional longevity, namely centenarians, and to assess the relationship between concentrations of TSH and free T(4) (FT4). DESIGN/SETTING/PATIENTS: We analyzed TSH, FT4, and TSH frequency distribution curves in thyroid disease-free Ashkenazi Jews with exceptional longevity (centenarians; median age, 98 yr), in younger Ashkenazi controls (median age, 72 yr), and in a population of thyroid disease-free individuals (median age, 68 yr) from the U.S. National Health and Nutrition Examination Survey 1998-2002 (NHANES controls). RESULTS: Serum TSH was significantly higher in centenarians [1.97 (0.42-7.15) mIU/liter] than in Ashkenazi controls [1.55 (0.46-4.55) mIU/liter] and NHANES controls [1.61 (0.39-6.29) mIU/liter] (median, 2.5 and 97.5 centiles) (P < 0.001). The TSH frequency distribution curve of centenarians was relatively similar in shape to controls but shifted significantly to higher TSH, including TSH concentration at peak frequency. The TSH distribution curve of the NHANES control group was superimposable to and not significantly different from the Ashkenazi controls. FT4 was similar in centenarians and Ashkenazi controls, and there was a significant inverse correlation between FT4 and TSH in both groups. CONCLUSIONS: The TSH population shifts to higher concentrations with age appear to be a continuum that extends even to people with exceptional longevity. The inverse correlation between TSH and FT4 in our populations suggests that changes in negative feedback may contribute to exceptional longevity.
Authors: G Ravaglia; P Forti; F Maioli; B Nesi; L Pratelli; L Savarino; D Cucinotta; G Cavalli Journal: J Clin Endocrinol Metab Date: 2000-06 Impact factor: 5.958
Authors: F Magri; B Muzzoni; L Cravello; M Fioravanti; L Busconi; D Camozzi; G Vignati; E Ferrari Journal: Metabolism Date: 2002-01 Impact factor: 8.694
Authors: Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman Journal: J Clin Endocrinol Metab Date: 2002-02 Impact factor: 5.958
Authors: Nir Barzilai; Gil Atzmon; Clyde Schechter; Ernst J Schaefer; Adrienne L Cupples; Richard Lipton; Suzanne Cheng; Alan R Shuldiner Journal: JAMA Date: 2003-10-15 Impact factor: 56.272
Authors: Martin I Surks; Eduardo Ortiz; Gilbert H Daniels; Clark T Sawin; Nananda F Col; Rhoda H Cobin; Jayne A Franklyn; Jerome M Hershman; Kenneth D Burman; Margo A Denke; Colum Gorman; Richard S Cooper; Neil J Weissman Journal: JAMA Date: 2004-01-14 Impact factor: 56.272
Authors: Digna R Velez Edwards; John R Gilbert; James E Hicks; Jamie L Myers; Lan Jiang; Anna C Cummings; Shengru Guo; Paul J Gallins; Ioanna Konidari; Laura Caywood; Lori Reinhart-Mercer; Denise Fuzzell; Claire Knebusch; Renee Laux; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines; William K Scott Journal: Age (Dordr) Date: 2012-07-07
Authors: Avantika C Waring; Alice M Arnold; Anne B Newman; Petra Bùzková; Calvin Hirsch; Anne R Cappola Journal: J Clin Endocrinol Metab Date: 2012-08-09 Impact factor: 5.958
Authors: Jennifer Yi-Chun Lai; Gil Atzmon; Michal L Melamed; Thomas H Hostetter; Jill P Crandall; Nir Barzilai; Markus Bitzer Journal: J Am Geriatr Soc Date: 2012-03-16 Impact factor: 5.562